Cell and Gene Therapy Manufacturing Services Market Report 2030
The cell and gene therapy manufacturing services market size is projected to reach US$ 26,724.90 million by 2030 from US$ 7,581.97 million in 2022. The market is expected to register a CAGR of 17.1% during 2022–2030. Automation of manufacturing services for cell and gene therapy is likely to remain a key trend in the market.
Cell and Gene Therapy Manufacturing Services Market Analysis
In recent years, the outsourced cell and gene manufacturing sector has undergone significant expansion and change. As cell and gene therapies progress, drug innovator firms are progressively depending on service providers to fulfill their manufacturing requirements. Outsourcing enables innovators to take advantage of the specialized expertise and capabilities of contract development and manufacturing organizations (CDMOs) to reduce costs and expedite time to market. The landscape of cell and gene therapy manufacturing has evolved over the past five years, with a shift towards more sophisticated platforms allowing scale-up, increased automation, and enhanced quality systems, shaping the contract manufacturing industry. With the growing number of approved cell and gene therapy products in the market each year, the need to enhance processes is becoming increasingly important.
Cell and Gene Therapy Manufacturing Services Market Overview
Both publicly and privately funded contract biopharmaceutical manufacturing has increased as a result of the surge in new biopharmaceutical products competing for approval. As a result, while established industry players are attempting to hold onto their positions and lead, new organizations are engaged in providing manufacturing services for cell and gene therapy. Healthcare policies in many regions now prioritize the ability to manufacture pharmaceutical (small molecule) products of all kinds. Additionally, a shift toward larger-molecule biomanufacturing, recombinant therapies, and increasingly complex biologics has occurred in many regions.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Manufacturing Services Market: Strategic Insights
Market Size Value in US$ 7,581.97 million in 2022 Market Size Value by US$ 26,724.90 million by 2030 Growth rate CAGR of 17.1% from 2022 to 2030 Forecast Period 2022-2030 Base Year 2022
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Cell and Gene Therapy Manufacturing Services Market: Strategic Insights
| Market Size Value in | US$ 7,581.97 million in 2022 |
| Market Size Value by | US$ 26,724.90 million by 2030 |
| Growth rate | CAGR of 17.1% from 2022 to 2030 |
| Forecast Period | 2022-2030 |
| Base Year | 2022 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Cell and Gene Therapy Manufacturing Services Market Drivers and Opportunities
Increase in Demand for Cell and Gene Therapy Manufacturing Favors Market Growth
Significant therapeutic advances in cell and gene therapy manufacturing services have resulted from the growing cell therapy research activities. The industry is striving to expand its manufacturing scale and overall accessibility to a broader population while emphasizing the advantages of advanced therapy medicinal products (ATMPs). The increasing complexity of personalized medicine necessitates the development of manufacturing capabilities to keep up with demand and guarantee patient access to these innovative treatments. Contract manufacturing now has more options due to the rise in global production. Funding for newly approved biopharmaceutical products, as well as contract biopharmaceutical manufacturing, has increased from both public and private sources. Worldwide organizations offer manufacturing services for cell and gene therapy, and well-established industry participants strive to sustain their operations. Thus, the emerging focus on the development of cell therapy manufacturing is likely to drive the growth of the market.
Strategic Initiatives by Key Players
Because of the rise in approvals and investments, there is an increasing need to manufacture therapies at preclinical, clinical, and commercial stages. Key players are making strategic development investments, which are opening up a lot of market opportunities. As an illustration of the rising need for cell and gene therapy manufacturing services, Bristol Myers Squibb and the start-up Cellares inked a $380 million deal in May 2024. In August 2023, Cellares completed a $255 million series C funding round, with BMS among the investors. Cellares will make chimeric antigen receptor (CAR) T-cell treatments for BMS. BMS will reserve spaces in Cellares' automated cell therapy manufacturing machines, or Cell Shuttle machines, in accordance with the terms of the agreement. With the money from the BMS sale, Cellares intends to open more locations in the US, Europe, and Japan in addition to running the ones in San Francisco and New Jersey.
Cell and Gene Therapy Manufacturing Services Market Report Segmentation Analysis
Key segments that contributed to the derivation of the cell and gene therapy manufacturing services market analysis are type, indication, application, and end user.
- Based on type, the cell and gene therapy manufacturing services market is divided into cell therapy and gene therapy. Cell therapy is further sub-segmented into autologous and allogeneic therapy. Gene Therapy is further sub-segmented into viral and non-viral vectors.
- By indication, the market is categorized into cancer, orthopedics, and others. The cancer segment held the largest share of the market in 2022.
- By application, the market is categorized into clinical manufacturing and commercial manufacturing. The commercial manufacturing segment held the largest share of the market in 2022.
- By end user, the market is segmented into pharmaceutical and biotechnology companies and contract research organizations (CROs). The pharmaceutical and biotechnology companies segment held the largest share of the market in 2022.
Cell and Gene Therapy Manufacturing Services Market Share Analysis by Geography
The geographic scope of the cell and gene therapy manufacturing services market report is mainly divided into five regions: North America, Asia Pacific, Europe, Middle East & Africa, and South & Central America.
The market for manufacturing services related to cell and gene therapy is anticipated to expand as a result of the rising demand for these products. This growth is linked to an increase in startups, an increase in R&D activities, and increased investments in the construction of cell and gene therapy manufacturing facilities in the US and Canada.
Additionally, for the forecast period, the Asia Pacific market has grown significantly at a robust CAGR. This growth can be attributed to a number of factors, including the growing need for advanced treatment solutions, favorable regulatory scenarios, and an increasing emphasis on research and development activities. Additionally, during the forecast period, the Asia Pacific market is expected to be driven by the expansion of healthcare infrastructure and rising investments meant to stimulate research activities.
Cell and Gene Therapy Manufacturing Services Market Report Scope
Cell and Gene Therapy Manufacturing Services Market News and Recent Developments
The cell and gene therapy manufacturing services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the cell and gene therapy manufacturing services market are listed below:
- RoslinCT and Lykan Bioscience, two leading Contract Development and Manufacturing Organizations (CDMOs) in the Cell and Gene Therapy industry, announce their integration, creating a unified business that will operate under the RoslinCT brand. The integration, facilitated by GHO Capital, a global investment firm, aims to establish a dominant player in the Advanced Cell and Gene Therapy CDMO market. (Source: RoslinCT, Press Release, June 2023)
- Cincinnati Children's Hospital Medical Center and the research service provider CTI Clinical Trial & Consulting Services have agreed to form a company that will focus on providing cell and gene therapy manufacturing services to the biotechnology and pharmaceutical industries. (Source: Cincinnati Children's Hospital Medical Center, Press Release, December 2021)
Cell and Gene Therapy Manufacturing Services Market Report Coverage and Deliverables
The “Cell and Gene Therapy Manufacturing Services Market Size and Forecast (2020–2030)” report provides a detailed analysis of the market covering below areas:
- Cell and gene therapy manufacturing services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Cell and gene therapy manufacturing services market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Cell and gene therapy manufacturing services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the cell and gene therapy manufacturing services market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Indication, Application, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the cell and gene therapy manufacturing services market in 2022
Key factors driving the market are increase in demand for cell and gene therapy manufacturing and the emergence of new startup service providers.
Automation of manufacturing services for cell and gene therapy is likely to remain a key trend in the market.
Thermo Fisher Scientific Inc, Merck KGaA, Charles River Laboratories International Inc, Lonza Group AG, WuXi AppTec Co Ltd, Catalent Inc, Takara Bio Inc, Nikon Corp, FUJIFILM Holdings Corp, National Resilience Inc, Oxford BioMedica Plc.
The market is expected to register a CAGR of 17.1% during 2022–2030.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Cell and Gene Therapy Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Cell and Gene Therapy Market - Key Industry Dynamics
5.1 Key Market Drivers:
5.1.1 Increase in Number of Approval of Cell and Gene Therapies
5.1.2 Increasing Popularity of Outsourcing Cell and Gene Therapy Manufacturing
5.2 Market Restraints
5.2.1 High Cost of Cell and Gene Therapy Manufacturing
5.3 Market Opportunities
5.3.1 Strategic Initiatives by Companies
5.4 Future Trends
5.4.1 Automation of Cell and Gene Therapy Manufacturing Services
5.5 Impact Analysis:
6. Cell and Gene Therapy Market - Global Market Analysis
6.1 Cell and Gene Therapy Market Revenue (US$ Mn), 2022 – 2030
7. Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Type
7.1 Overview
7.2 Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
7.3 Cell Therapy
7.3.1 Overview
7.3.2 Cell Therapy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.1 Autologous
7.3.2.1.1 Overview
7.3.2.1.2 Autologous: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.3.2.2 Allogenic
7.3.2.2.1 Overview
7.3.2.2.2 Allogenic: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Gene Therapy
7.4.1 Overview
7.4.2 Gene Therapy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.1 Viral Vector
7.4.2.1.1 Overview
7.4.2.1.2 Viral Vector: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
7.4.2.2 Non-Viral Vector
7.4.2.2.1 Overview
7.4.2.2.2 Non-Viral Vector: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8. Cell and Gene Therapy Manufacturing Services Market Analysis and Forecasts to 2030 – by Indication
8.1 Overview
8.2 Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
8.3 Cancer
8.3.1 Overview
8.3.2 Cancer: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Orthopedics
8.4.1 Overview
8.4.2 Orthopedics: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9. Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by Application
9.1 Overview
9.2 Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
9.4 Clinical Manufacturing
9.4.1 Overview
9.4.2 Clinical Manufacturing: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
9.5 Commercial Manufacturing
9.5.1 Overview
9.5.2 Commercial Manufacturing: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
10. Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – by End User
10.1 Overview
10.2 Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
10.4 Pharmaceutical and Biotechnology Companies
10.4.1 Overview
10.4.2 Pharmaceutical & Biotechnology Companies: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
10.5 Contract Research Organizations (CROs)
10.5.1 Overview
10.5.2 Contract Research Organizations (CROs): Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11. Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 – Regional Analysis
11.1 North America: Cell and Gene Therapy Manufacturing Services Market
11.1.1 Overview
11.1.2 North America: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.3 North America: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.1.3.1 North America: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.1.3.2 North America: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.1.4 North America: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.1.5 North America: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.1.6 North America: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.1.7 North America: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
11.1.7.1 US: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.1.1 US: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.1.7.1.1.1 US: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.1.7.1.1.2 US: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.1.7.1.2 US: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.1.7.1.3 US: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.1.7.1.4 US: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.1.7.2 Canada: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.2.1 Canada: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.1.7.2.1.1 Canada: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.1.7.2.1.2 Canada: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.1.7.2.2 Canada: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.1.7.2.3 Canada: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.1.7.2.4 Canada: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.1.7.3 Mexico: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.1.7.3.1 Mexico: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.1.7.3.1.1 Mexico: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.1.7.3.1.2 Mexico: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.1.7.3.2 Mexico: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.1.7.3.3 Mexico: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.1.7.3.4 Mexico: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2 Europe: Cell and Gene Therapy Manufacturing Services Market
11.2.1 Overview
11.2.2 Europe: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.3 Europe: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.3.1 Europe: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.3.2 Europe: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.4 Europe: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.5 Europe: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.6 Europe: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7 Europe: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
11.2.7.1 Germany: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.1.1 Germany: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.1.1.1 Germany: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.1.1.2 Germany: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.1.2 Germany: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.1.3 Germany: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.1.4 Germany: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.2 UK: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.2.1 UK: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.2.1.1 UK: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.2.1.2 UK: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.2.2 UK: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.2.3 UK: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.2.4 UK: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.3 France: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.3.1 France: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.3.1.1 France: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.3.1.2 France: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.3.2 France: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.3.3 France: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.3.4 France: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.4 Italy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.4.1 Italy: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.4.1.1 Italy: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.4.1.2 Italy: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.4.2 Italy: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.4.3 Italy: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.4.4 Italy: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.5 Spain: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.5.1 Spain: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.5.1.1 Spain: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.5.1.2 Spain: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.5.2 Spain: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.5.3 Spain: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.5.4 Spain: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.2.7.6 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.2.7.6.1 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.2.7.6.1.1 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.2.7.6.1.2 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.2.7.6.2 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.2.7.6.3 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.2.7.6.4 Rest of Europe: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market
11.3.1 Overview
.
11.3.2 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.3 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.3.1 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.3.2 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.4 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.5 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.6 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7 Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
11.3.7.1 China: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.1.1 China: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.1.1.1 China: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.1.1.2 China: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.1.2 China: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.1.3 China: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.1.4 China: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7.2 Japan: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.2.1 Japan: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.2.1.1 Japan: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.2.1.2 Japan: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.2.2 Japan: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.2.3 Japan: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.2.4 Japan: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7.3 India: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.3.1 India: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.3.1.1 India: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.3.1.2 India: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.3.2 India: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.3.3 India: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.3.4 India: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7.4 Australia: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.4.1 Australia: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.4.1.1 Australia: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.4.1.2 Australia: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.4.2 Australia: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.4.3 Australia: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.4.4 Australia: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7.5 South Korea: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.5.1 South Korea: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.5.1.1 South Korea: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.5.1.2 South Korea: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.5.2 South Korea: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.5.3 South Korea: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.5.4 South Korea: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.3.7.6 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.3.7.6.1 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.3.7.6.1.1 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.3.7.6.1.2 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.3.7.6.2 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.3.7.6.3 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.3.7.6.4 Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.4 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market
11.4.1 Overview
11.4.2 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.4.3 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.4.3.1 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.4.3.2 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.4.4 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.4.5 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.4.6 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.4.7 Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
11.4.7.1 South Africa: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.1.1 South Africa: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.4.7.1.1.1 South Africa: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.4.7.1.1.2 South Africa: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.4.7.1.2 South Africa: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.4.7.1.3 South Africa: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.4.7.1.4 South Africa: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.4.7.2 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.2.1 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.4.7.2.1.1 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.4.7.2.1.2 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.4.7.2.2 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.4.7.2.3 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.4.7.2.4 Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.4.7.3 UAE: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.3.1 UAE: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.4.7.3.1.1 UAE: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.4.7.3.1.2 UAE: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.4.7.3.2 UAE: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.4.7.3.3 UAE: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.4.7.3.4 UAE: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.4.7.4 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.4.7.4.1 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.4.7.4.1.1 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.4.7.4.1.2 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.4.7.4.2 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.4.7.4.3 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.4.7.4.4 Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.5 South & Central America: Cell and Gene Therapy Manufacturing Services Market
11.5.1 Overview
11.5.2 South & Central America: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.5.3 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.5.3.1 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.5.3.2 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.5.4 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.5.5 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.5.6 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.5.7 South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
11.5.7.1 Brazil: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.1.1 Brazil: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.5.7.1.1.1 Brazil: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.5.7.1.1.2 Brazil: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.5.7.1.2 Brazil: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.5.7.1.3 Brazil: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.5.7.1.4 Brazil: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.5.7.2 Argentina: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.2.1 Argentina: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.5.7.2.1.1 Argentina: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.5.7.2.1.2 Argentina: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.5.7.2.2 Argentina: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.5.7.2.3 Argentina: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.5.7.2.4 Argentina: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
11.5.7.3 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
11.5.7.3.1 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Type, 2020–2030 (US$ Million)
11.5.7.3.1.1 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Cell Therapy, 2020–2030 (US$ Million)
11.5.7.3.1.2 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Gene Therapy, 2020–2030 (US$ Million)
11.5.7.3.2 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Indication, 2020–2030 (US$ Million)
11.5.7.3.3 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Application, 2020–2030 (US$ Million)
11.5.7.3.4 Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market, by End User, 2020–2030 (US$ Million)
12. Cell and Gene Therapy Manufacturing Services Market – Industry Landscape
12.1 Overview
12.2 Growth Strategies in Cell and Gene Therapy Manufacturing Services Market
12.3 Organic Growth Strategies
12.3.1 Overview
12.4 Inorganic Growth Strategies
12.4.1 Overview
13. Company Profiles
13.1 Thermo Fisher Scientific Inc
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Merck KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Charles River Laboratories InternationalInc
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Lonza Group AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 WuXi AppTec Co Ltd?
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Catalent Inc
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Takara Bio Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Nikon Corp
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FUJIFILM Holdings Corp
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 National Resilience Inc
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
13.11 Oxford BioMedica Plc
13.11.1 Key Facts
13.11.2 Business Description
13.11.3 Products and Services
13.11.4 Financial Overview
13.11.5 SWOT Analysis
13.11.6 Key Developments
List of Tables
Table 1. Cell and Gene Therapy Market Segmentation
Table 2. Recent Organic Growth Strategies in Cell and Gene Therapy Manufacturing Services Market
Table 3. Recent Inorganic Growth Strategies in the Cell and Gene Therapy Manufacturing Services Market
List of Figures
Figure 1. Cell and Gene Therapy Market Segmentation, By Geography
Figure 2. PEST Analysis
Figure 3. Cell and Gene Therapy Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Cell and Gene Therapy Market Revenue (US$ Mn), 2022 – 2030
Figure 6. Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Type 2022 & 2030 (%)
Figure 7. Cell Therapy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Autologous: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Allogenic: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Gene Therapy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Viral Vector: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Non-Viral Vector: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Cell and Gene Therapy Manufacturing Services Market, by Indication 2022 & 2030 (%)
Figure 14. Cancer: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Orthopedics: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Cell and Gene Therapy Manufacturing Services Market Revenue Share, by Application 2022 & 2030 (%)
Figure 18. Clinical Manufacturing: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Commercial Manufacturing: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Cell and Gene Therapy Manufacturing Services Market Revenue Share, by End User 2022 & 2030 (%)
Figure 21. Pharmaceutical & Biotechnology Companies: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Contract Research Organizations (CROs): Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. North America: Cell and Gene Therapy Manufacturing Services Market, by Key Region – Revenue (2022) (US$ Million)
Figure 24. North America Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
Figure 26. US: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Europe: Cell and Gene Therapy Manufacturing Services Market, by Key Region – Revenue (2022) (US$ Million)
Figure 30. Europe Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 31. Europe: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
Figure 32. Germany: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 33. UK: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 34. France: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 35. Italy: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 36. Spain: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 37. Rest of Europe: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 38. Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Key Region – Revenue (2022) (US$ Million)
Figure 39. Asia Pacific Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 40. Asia Pacific: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
Figure 41. China: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 42. Japan: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 43. India: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 44. Australia: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 45. South Korea: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 46. Rest of Asia Pacific: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 47. Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Key Region – Revenue (2022) (US$ Million)
Figure 48. Middle East & Africa Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 49. Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
Figure 50. South Africa: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 51. Saudi Arabia: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 52. UAE: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 53. Rest of Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 54. South & Central America: Cell and Gene Therapy Manufacturing Services Market, by Key Region – Revenue (2022) (US$ Million)
Figure 55. South & Central America Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 56. Middle East & Africa: Cell and Gene Therapy Manufacturing Services Market, by Region, 2022 & 2030 (%)
Figure 57. Brazil: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 58. Argentina: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 59. Rest of South & Central America: Cell and Gene Therapy Manufacturing Services Market – Revenue and Forecast to 2030 (US$ Million)
Figure 60. Growth Strategies in Cell and Gene Therapy Manufacturing Services Market
The List of Companies - Cell and Gene Therapy Manufacturing Services Market
- Thermo Fisher Scientific Inc
- Merck KGaA
- Charles River Laboratories International Inc
- Lonza Group AG
- WuXi AppTec Co Ltd
- Catalent Inc
- Takara Bio Inc
- Nikon Corp
- FUJIFILM Holdings Corp
- National Resilience Inc,
- Oxford BioMedica Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For